Home » Hemispherx Ending Licensing Deal in Spain, Portugal and Andorra
Hemispherx Ending Licensing Deal in Spain, Portugal and Andorra
Hemispherx Biopharma Inc. said Monday it plans to terminate a license agreement that gives Laboratorios Del Dr. Esteve the right to market Ampligen for chronic fatigue syndrome in Spain, Portugal and Andorra.
Philadelphia Business Journal
Philadelphia Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May